Working… Menu

Phase 2, Open-Label, Single Arm Study, With BST-236 in Adults With R/R AML or Higher-Risk MDS

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04749355
Recruitment Status : Not yet recruiting
First Posted : February 11, 2021
Last Update Posted : February 15, 2021
Information provided by (Responsible Party):
BioSight Ltd.

No Study Results Posted on for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : August 14, 2022
Estimated Study Completion Date : March 14, 2024